Chemistry · Ch 16 — Chemistry in Everyday Life
Drug-enzyme interaction
Drug-enzyme interaction
Two Chemically Distinct Modes of Enzyme Inhibition
A drug can interfere with an enzyme's activity by acting as an inhibitor, and there are two chemically distinct ways this can happen:
- Competitive inhibition. The drug molecule is structurally similar enough to the natural substrate that it can physically occupy the same active site, directly competing with the substrate for that space. Once the drug is bound there, the true substrate is excluded and the normal reaction cannot proceed. Figure 16.2's cover art depicts exactly this competition - a drug and a substrate both approaching the same active-site notch, followed by the drug winning that competition and blocking the site outright.
- Non-competitive inhibition. Here the drug does not go anywhere near the active site at all. Instead it binds at a separate, distinct location on the enzyme called the allosteric site. This binding event distorts the overall three-dimensional shape of the enzyme, which in turn changes the shape of the active site itself - so that the substrate can no longer be recognised or bound there, even though the active site is physically unoccupied by the drug. Figure 16.3's cover art shows this shape-change explicitly: the active site is redrawn as a flattened, altered groove once the inhibitor has taken up residence at the separate allosteric notch. …
What this figure shows. Two-panel schematic. Left panel: a purple enzyme block labelled 'Enzyme' with a V-shaped 'Active site'; nearby a green trapezoidal wedge labelled 'Drug' (shown twice, with arrows) and a pink trapezoidal wedge labelled 'Substrate' both point toward the active site; captioned below 'Drug and substrate competing for active site of enzyme'. Right panel: the green 'Drug' wedge is now shown seated in/blocking the enzyme's active site while the pink 'substrate' wedge sits unbound off to the side; captioned below 'Drug …
What this figure shows. Two-panel schematic. Left panel: the purple enzyme block with its normal V-shaped 'Active site' at the top and a separate small notch labelled 'Allosteric site' lower on the block, next to a small orange square labelled 'Inhibitor' (with an arrow pointing to the allosteric site). Right panel: after the orange inhibitor occupies the allosteric site ('Inhibitor occupying allosteric site'), the formerly V-shaped active site is redrawn as a flattened, curved groove labelled 'Active site with changed shape', showing the substrate can no longer recognise it. …